Patent · US Active

Method for screening for an anti-CD4 antibody suitable for use in immunotherapy

US8685651B2 · kind B2 · utility

1Cited by

17References

3Claims

0Family size

Assignee

Biotest AG · DE

Inventors

John Wijdenes · Larnod, FR
Helmut Jonuleit · Ginsheim-Gustavsburg, DE

Key dates

Filing date	Feb 25, 2009
Grant date	Apr 1, 2014
Priority date	—
Expiry date	Feb 25, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/73
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A humanized antibody derived from mouse monoclonal anti-CD4 antibody B-F5 is able to activate CD25+CD4+ regulatory T cells and is useful for preparing immunosuppressive compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.